These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8801593)

  • 61. The putative somatostatin antagonist cyclo-somatostatin has opioid agonist effects in gastrointestinal preparations.
    Benko R; Antwi A; Bartho L
    Life Sci; 2012 May; 90(19-20):728-32. PubMed ID: 22483686
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of naloxone and opioid agonists on gastric excitatory responses to stimulation of the vagus nerve in cats.
    Okamoto T; Kurahashi K; Fujiwara M
    Br J Pharmacol; 1988 Oct; 95(2):329-34. PubMed ID: 2906554
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions.
    Evans RG; Ludbrook J; Van Leeuwen AF
    J Physiol; 1989 Dec; 419():15-31. PubMed ID: 2559974
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lack of effect of gamma-hydroxybutyrate on mu, delta and kappa opioid receptor binding.
    Feigenbaum JJ; Simantov R
    Neurosci Lett; 1996 Jul; 212(1):5-8. PubMed ID: 8823749
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The agonist and antagonist properties of N-allylenkephalins.
    Hahn EF; Fishman J; Shiwaku Y; Foldes FF; Nagashima H; Duncalf D
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):1-9. PubMed ID: 198860
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia.
    Audigier Y; Mazarguil H; Gout R; Cros J
    Eur J Pharmacol; 1980 Apr; 63(1):35-46. PubMed ID: 6247160
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human leumorphin is a potent, kappa opioid receptor agonist.
    Suda M; Nakao K; Yoshimasa T; Sakamoto M; Morii N; Ikeda Y; Yanaihara C; Yanaihara N; Numa S; Imura H
    Neurosci Lett; 1984 Sep; 50(1-3):49-52. PubMed ID: 6149506
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis and opioid activities of [D-Leu-8]Dynorphin(1-8) analogs containing a reduced peptide bond, psi(CH2-NH).
    Ambo A; Adachi T; Sasaki Y
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1547-50. PubMed ID: 7586080
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
    Dissanayake VU; Hughes J; Hunter JC
    Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
    Fuchs PN; Roza C; Sora I; Uhl G; Raja SN
    Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of opiate-mediated responses of the feline ileum and ileocecal sphincter.
    Ouyang A; Clain CJ; Snape WJ; Cohen S
    J Clin Invest; 1982 Mar; 69(3):507-15. PubMed ID: 6277992
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.
    James MK; Feldman PL; Schuster SV; Bilotta JM; Brackeen MF; Leighton HJ
    J Pharmacol Exp Ther; 1991 Nov; 259(2):712-8. PubMed ID: 1658308
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.
    Dray A; Nunan L; Wire W
    Br J Pharmacol; 1985 Jul; 85(3):717-26. PubMed ID: 2992671
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of kappa-opioid receptors in the guinea-pig ileum.
    Dissanayake VU; Hunter JC; Hill RG; Hughes J
    Eur J Pharmacol; 1990 Jun; 182(1):73-82. PubMed ID: 2169427
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The in vitro pharmacological characterization of naloxone benzoylhydrazone.
    Berzetei-Gurske IP; White A; Polgar W; DeCosta BR; Pasternak GW; Toll L
    Eur J Pharmacol; 1995 Apr; 277(2-3):257-63. PubMed ID: 7493617
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional antagonism by calcium of an intrinsic opioid mechanism in the guinea-pig isolated ileum.
    Kromer W; Scheiblhuber E; Illes P
    Neuropharmacology; 1980 Sep; 19(9):839-43. PubMed ID: 6252505
    [No Abstract]   [Full Text] [Related]  

  • 78. Involvement of different receptor subtypes for the production of in vitro and in vivo effects in a series of synthetic enkephalin analogues.
    Watanabe J; Kaneto H; Maeda M; Tsuji T; Kawasaki K
    J Pharmacobiodyn; 1985 Nov; 8(11):975-80. PubMed ID: 3005543
    [TBL] [Abstract][Full Text] [Related]  

  • 79. N-cubylmethyl substituted morphinoids as novel narcotic antagonists.
    Cheng CY; Hsin LW; Lin YP; Tao PL; Jong TT
    Bioorg Med Chem; 1996 Jan; 4(1):73-80. PubMed ID: 8689242
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An opioid pancreatic peptide produces ileal muscle inhibition and naloxone-reversible analgesia.
    Kimball CD; Iqbal M; Huang JT; Sutton D
    Pharmacol Biochem Behav; 1991 Apr; 38(4):909-12. PubMed ID: 1651521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.